Alpha Tau Reports Breakthrough Interim Results in Brain Cancer Trial: 100% Disease Control and 67% Complete Response

Alpha Tau’s brain cancer trial shows 2/3 glioblastoma patients’ tumors disappeared, all controlled, with good safety so far.